Author:
Messina Antonella,Calareso Giuseppina,Alessi Alessandra
Publisher
Springer International Publishing
Reference36 articles.
1. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. SEER stat fact sheets: bladder cancer.
2. Soukup V, Capoun O, Cohen D, et al. Prognostic performance and reproducibility of the 1973 and 2004/2016 World Health Organization Grading classification systems in non-muscle-invasive bladder cancer: a European Association of Urology non-muscle invasive bladder cancer guidelines panel systematic review. Eur Urol. 2017;72:801–13.
3. Babjuk M, Bohle A, Burger M, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71:447–61.
4. Sylvester RJ, van der Meijden GP, Sylvester R, Pisano F, et al. Prognostic factors and risk treated with Bacillus Calmette-Guerin: results of a retrospective multicenter study of 2451 patients. Eur Urol. 2015;67:74–82.
5. National Collaborating Center for Cancer. Accessed 1 Nov 2017. Bladder cancer: diagnosis and management. https://www.ncbi.nlm.nih.gov/books/NBK305022/pdf/Bookshelf_NBK305022.pdf.